< 1 minute read
Sep. 15, 2021

Molecules of the Month - February 2020

GS-9876 (lanraplenib)

SYK-selective kinase inhibitor oral, completed Ph. I in HV from optimization of prior candidate ACS Med. Chem. Lett. Feb. 12, 2020 Gilead Sciences, Seattle, WA

twitterlinkedinprintemail